Biotechnology News

April 19, 2012

LEBANON, N.H.--(BUSINESS WIRE)--Adimab, LLC, a technology leader in the discovery of fully human therapeutic antibodies, today announced the initiation of two new independent research collaborations. Adimab and Gilead Sciences, Inc. (Nasdaq:GILD...

April 19, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced that Christopher L. Burnley has been appointed chief business officer. Mr...

April 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will release its first-quarter 2012 financial results before the market opens on Thursday, May 3, 2012.

April 19, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Restoration Robotics, Inc. today announced that their revolutionary ARTAS® System will be featured at the Orlando Live Surgery Workshop (OLSW) sponsored by the International Society of Hair Restoration...

April 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Pfizer Remained Top Pharmaceutical Company by Sales in 2011, But Novartis Should Take the Top Ranking by 2015, According to New Data from Decision Resources

April 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announced that its Biologics Support Center in Framingham received a Gold certification under the Green Building Council's LEED Rating System. This is the 10th building to receive the honor.

April 19, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today posted solid first quarter financial results which exceeded the company’s previously issued revenue and earnings per share (EPS) guidance. For the first quarter, Baxter...

April 19, 2012

KFAR SABA, Israel--(BUSINESS WIRE)--NLT SPINE announced that its eSpin discectomy device has received CE Mark approval, enabling the company to market it in Europe.

April 19, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals is announcing that the Company is to be added to the S&P SmallCap 600 Index at the close of trading on Tuesday, April 24th, 2012.

April 19, 2012

PRAGUE--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor immune status in transplant recipients and autoimmune...

April 19, 2012

BARCELONA, Spain--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced final results from a Phase III, open-label study designed to compare the impact of two anemia management strategies on sustained...

April 19, 2012

BARCELONA, Spain--(BUSINESS WIRE)--MSD (NYSE: MRK), known as Merck in the United States and Canada, announced final results from a Phase III, open-label study designed to compare the impact of two anaemia management strategies on sustained...

April 19, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended March 31, 2012. First Quarter Results Net earnings were $161.6 million and earnings per diluted...

April 19, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter today announced it will build a new state-of-the-art manufacturing facility in Georgia to support growth of its plasma-based treatments.

April 19, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has received an unsolicited proposal from GlaxoSmithKline plc (GSK) to acquire HGS for $13.00 per share in cash. The HGS Board of Directors, in...

April 19, 2012

BARCELONA, Spain--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced interim data from a Phase 2 trial (ATOMIC) examining a 12-week course of treatment with the once-daily nucleotide GS-7977 plus pegylated interferon (Peg-IFN)...

April 19, 2012

BARCELONA, Spain--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced interim data from the Phase 2 ELECTRON study examining the investigational once-daily oral agent GS-7977 plus ribavirin (RBV) in treatment-naïve patients with...

April 19, 2012

BARCELONA, Spain & INGELHEIM, Germany--(BUSINESS WIRE)--Data to be presented at The International Liver Congress on Boehringer Ingelheim's interferon-free hepatitis C data in cirrhotic patients.

April 19, 2012

BARCELONA, Spain & INGELHEIM, Germany--(BUSINESS WIRE)--Data to be presented at The International Liver Congress 2012 on Boehringer Ingelheim's interferon-free trial in hepatitis C.

April 18, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” NYSE: TARO) announced today that Mr. Dilip Shanghvi has resigned, effective today, as Chairman and a member of Taro's Board of Directors (“Board”) in order to focus on...

April 18, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 27,...

April 18, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the first quarter ended March 31, 2012. The Company will host a conference call and webcast today at 5:00 p.m. ET (details below)....

April 18, 2012

SAN DIEGO--(BUSINESS WIRE)--Molecular Response Opens Access to Genomic DNA for Research

April 18, 2012

NEW YORK--(BUSINESS WIRE)--Needham & Company, LLC, a privately held, full-service investment bank, announced today that Chad Messer recently joined the firm as a Senior Research Analyst covering the biotechnology sectors. He will be based in...

April 18, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) announced today that scientists at the Gladstone Institute of Cardiovascular Disease, University of California, San...

April 18, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: On 18 April 2012 mandatory notification of trade among primary insider Praveen Sharma of DiaGenic ASA (OSE:DIAG) took place. Capveen AS, which is controlled by Sharma, has sold 266,213 shares to...

April 18, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced the Agilent 1290 Infinity Quaternary LC system, the first quaternary UHPLC system to deliver the accuracy and precision of binary systems. The new Agilent...

April 18, 2012

MIRAMAR, Fla.--(BUSINESS WIRE)--CRO industry veteran, Christopher Ore leads business development and operations at Comprehensive Clinical Development.

April 18, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) reports Prof. Gunzburg will present the innovative living cell encapsulation cancer treatment at the OOTR meeting in Kyoto.

April 18, 2012

DUBAI, United Arab Emirates--(BUSINESS WIRE)--1 Mission 1 Million – Getting to the Heart of Stroke announces plans to launch an exciting new phase of the initiative. Campaign sponsor Boehringer Ingelheim, in collaboration with AntiCoagulation...

April 18, 2012

CASTLE ROCK, Colo.--(BUSINESS WIRE)--Clinical Study Suggests One-Third of CT Scans Used to Assess Pediatric and Adolescent Patients at Low Risk for Acute Appendicitis Could Potentially Be Avoided

April 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. rheumatologists indicate that they would prescribe Ardea Biosciences...

April 18, 2012

CAMBRIDGE, Mass. & COLOGNE, Germany--(BUSINESS WIRE)--Metabolix today announced the opening of its new office in Cologne, Germany. This will enable the Company to directly access the European market for biopolymers.

April 18, 2012

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Crimson Life Sciences was awarded the world's first translation risk management patent to advance “state of the art” and help manufacturers satisfy ISO 14971 risk management requirements.

April 18, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D. will present at...

April 18, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles’ embrace of digital media has received acclaim for helping employees connect and work together more effectively, winning the Ragan Communication Awards for "Best Social Intranet."

April 18, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that data from the ASCEND-PD Phase III clinical study involving IPX066 will be presented in a...

April 18, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta presented results that show ganetespib equally inhibits growth of both crizotinib-sensitive and -resistant cancer cells driven by the EML4-ALK fusion protein regardless of ALK mutation status.

April 18, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation announces 2-year supply agreement with its first INTERCEPT platelet customer in Austria, the General Hospital of Vienna (AKH).

April 18, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”)(OTCBB: IMUC-NEWS), a clinical stage biotechnology company that is focused on developing new immune-based products to treat and diagnose cancer,...

April 18, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--RedHill Biopharma announces positive results in an advanced bioequivalence clinical trial with RHB-102 for the prevention of nausea and vomiting in cancer patients.

April 18, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife’s (STO:VITR) Board has today appointed Thomas Axelsson as the new CEO of Vitrolife. Thomas has been working as the Acting CEO of the Group since November 2011. Thomas Axelsson has...

April 18, 2012

JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced new data from the Company’s expanding central nervous system (CNS) portfolio will be featured at the 64th American Academy of Neurology (AAN)...

April 18, 2012

PHILADELPHIA--(BUSINESS WIRE)--Key Hires from Novartis and Pfizer to Support Development and Commercialization of Novel Sub-micron Particle NSAIDS

April 18, 2012

BARCELONA, Spain--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that 30 abstracts examining the company’s products and investigational agents for hepatitis B and C have been selected for presentation at the 47th Annual...

April 18, 2012

FREIENBACH, Switzerland--(BUSINESS WIRE)--Mission, EffRx, osteoporosis, bone health, effervescent, alendronate sodium, binosto, ex101

April 18, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and answer session, Tuesday, April 24, 2012. During the call, management will discuss the Company’s financial results...